 Edge Therapeutics, a Berkeley Heights, N.J.-based clinical-stage biotechnology company, raised approximately 72.5m in funding. The proceeds came from two private financing rounds. The most recent round, a 56m Series C-2 financing, was completed in April 2015. It was led by Venrock with participation of Sofinnova Ventures, Janus Capital Management LLC, funds managed by Franklin Advisers, Inc., ... 